The Training of Tyroserleutide Phase III Clinical Trial in the Affiliated Tumor Hospital of Sun Yat-sen University

Date:
2011-09-27
Category:
Company News

This training of Tyroserleutide Phase III clinical trial in the Affiliated Tumor Hospital of Sun Yat-sen University was held at the conference room of hepatobiliary surgery department on 8th September 2011, and around 30 people from the hepatobiliary surgery department attended. The vice-present of Kangzhe Pharmaceutical Research and Development(Shenzhen)Limited introduced the research process of Tyroserleutide as well as the background and the prospect of the Tyroserleutide Phase III clinical trial, our medical department also introduced the protocol, operation procedure and standardized procedure of Tyroserleutide Phase III clinical trial. Medpace (the Clinical Research Organization of this clinical trial) also explained Good Clinical Practice rules for us. The success of this training laid a solid foundation for the Phase III clinical research of Tyroserleutide.